CN107981141A - 一种中老年保健饮品及其制备方法 - Google Patents
一种中老年保健饮品及其制备方法 Download PDFInfo
- Publication number
- CN107981141A CN107981141A CN201711288925.0A CN201711288925A CN107981141A CN 107981141 A CN107981141 A CN 107981141A CN 201711288925 A CN201711288925 A CN 201711288925A CN 107981141 A CN107981141 A CN 107981141A
- Authority
- CN
- China
- Prior art keywords
- parts
- health care
- raw material
- water
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title abstract description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 54
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 54
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 50
- 239000002994 raw material Substances 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 30
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 27
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 27
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 27
- 229960000304 folic acid Drugs 0.000 claims abstract description 27
- 235000019152 folic acid Nutrition 0.000 claims abstract description 27
- 239000011724 folic acid Substances 0.000 claims abstract description 27
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 27
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 27
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 27
- 239000000843 powder Substances 0.000 claims abstract description 26
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 26
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 25
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 25
- 239000011718 vitamin C Substances 0.000 claims abstract description 25
- 102000008186 Collagen Human genes 0.000 claims abstract description 24
- 108010035532 Collagen Proteins 0.000 claims abstract description 24
- 229920001491 Lentinan Polymers 0.000 claims abstract description 23
- 229940115286 lentinan Drugs 0.000 claims abstract description 23
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 22
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 229920001436 collagen Polymers 0.000 claims description 3
- 235000019504 cigarettes Nutrition 0.000 claims 1
- 230000004089 microcirculation Effects 0.000 abstract description 10
- 210000000056 organ Anatomy 0.000 abstract description 6
- 210000005036 nerve Anatomy 0.000 abstract description 5
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 230000002792 vascular Effects 0.000 abstract description 3
- 230000004913 activation Effects 0.000 abstract description 2
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 235000013361 beverage Nutrition 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 150000004676 glycans Chemical class 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 235000013599 spices Nutrition 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical compound OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 229930189092 Notoginsenoside Natural products 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000002391 femur head Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明涉及保健品领域,尤其涉及一种中老年保健饮品及其制备方法,由以下质量份数的原料组成,三七粉0.5‑1份、牛骨胶原蛋白肽1.5‑2份、叶酸0.3‑0.6份、烟酸0.6‑1.2份、维生素C 0.6‑1.5份、香菇多糖0.5‑1份、水94‑96份,该中老年保健饮品能够快速疏通全身血管,活化通身神经,改善微循环,血液营养通过微循环输送至各个器官,保证身体各器官的正常工作,起到预防和辅助治疗心脑血管疾病的目的。
Description
技术领域
本发明涉及保健品领域,尤其涉及一种中老年保健饮品及其制备方法。
背景技术
人在三十岁之后,人体微循环陆续会出现不通的现象,导致人体微循环产生不同程度的阻塞,血管发生堵塞,血液流不到细胞中,细胞缺血缺氧,脑细胞缺氧会引起头晕、头痛、失眠、记忆力下降,慢慢会使脑细胞萎缩,当萎缩到50-70%时会引起痴呆病,脑细胞阻塞血管变硬,压迫脑细胞使运动神经中枢控制运动神经的能力失控,引起侧肢体瘫痪,整个脑细胞压迫引起全瘫,心肌梗塞,心脏细胞缺血缺氧,身体的直接反应就是心跳弱、心律不齐,出现心悸、心慌,严重损害了人们的身体健康。而现有的用于疏通人体微循环的保健品,在人体中被人体吸收转化率较低,有效成分难以被人体吸收。
发明内容
本发明的目的在于克服当前的中老年保健饮品的吸收转化率低的问题,而提供一种中老年保健饮品,该中老年保健饮品能够快速疏通全身血管,活化通身神经,改善微循环,血液营养通过微循环输送至各个器官,保证身体各器官的正常工作,起到预防和辅助治疗心脑血管疾病的目的。
本发明是这样实现的:
一种中老年保健饮品,由以下质量份数的原料组成,三七粉0.5-1份、牛骨胶原蛋白肽1.5-2份、叶酸0.3-0.6份、烟酸0.6-1.2份、维生素C 0.6-1.5份、香菇多糖0.5-1份、水93-96份。
优选的,由以下质量份数的原料组成,三七粉0.7-0.9份、牛骨胶原蛋白肽1.6-1.9份、叶酸0.4-0.5份、烟酸0.8-1份、维生素C 0.9-1.2份、香菇多糖0.6-0.9份、水94-95份。
优选的,由以下质量份数的原料组成,三七粉0.8份、牛骨胶原蛋白肽1.7份、叶酸0.45份、烟酸0.9份、维生素C 1份、香菇多糖0.85份、水94.3份。
一种制备上述的中老年保健饮品的方法,包括以下步骤:按照以下重量份数称取原料:三七粉0.5-1份、牛骨胶原蛋白肽1.5-2份、叶酸0.3-0.6份、烟酸0.6-1.2份、维生素C0.6-1.5份、香菇多糖0.5-1份;将以上原料放入容皿中,按照原料:水为1:25-1:10的比例向容皿中加入水,中火熬制12-20分钟后,过滤,取滤液,加入纯净水进行稀释,稀释浓度达到4%-7.3%,装瓶即可。
本发明具有以下的优点:
本发明的中老年保健饮品,采用三七粉、牛骨胶原蛋白肽、叶酸、烟酸、维生素C、香菇多糖,其中,三七粉自身具有扩张血管,溶解血栓,改善微循环的功能,当三七粉进入人体之后,能够溶解血管内血栓,加速血液流速,帮助血液将毒素排出、溶脂排脂;而叶酸与烟酸配伍之后在本发明中共同作用起到消栓通络的作用,叶酸与烟酸能够促进人体体内快速形成生物电,在3-5分钟之内,从人体的头部逐渐向下,依次疏通各个部位的血管,进而活化通身神经,而牛骨胶原蛋白属于小分子肽,对于中老年人来说,更有利于中老年人肽骨吸收,对中老年骨骼、骨关节、缺钙、骨质疏松有很好改善效果,与三七粉、叶酸与烟酸的统统作用下,激活衰老细胞;而香菇多糖属于小分子糖,在衰老细胞被激活之后,香菇多糖及时给予补充营养,避免细胞死亡,香菇多糖与维生素C在本发明中通过配比,维生素C、香菇多糖辅助细胞恢复活性,从而提高衰老细胞的生理活性。本发明针对多种心脑血管疾病患者和不同的中老年人进行临床治疗,综合不同症状的疗效,得到本发明的保健饮品的最适合的配比,使得采用该配比的各原料的保健饮品在进入至人体之后,迅速消栓通络,打通微循环,清除血管内壁多年沉积的脂质物,使血液营养通过微循环输送至各个器官,由于微动脉、微静脉管径很细,只有头发的1/20,只允许1-2个红细胞通过,所以使用本发明的保健饮品后,短时间内全身血管被疏通,血液流速恢复正常,以保证了该保健饮品和其他饮食中的营养物质最大可能的被组织细胞周围的最微细的微动脉、微静脉吸收,满足100亿细胞参与生命活动的需要,进而促进身体各器官的正常工作,增强人体免疫,达到预防和辅助治疗心脑血管疾病的治疗效果。
本发明中各原料的药理药效:
三七粉:富含三七皂苷、三七多糖、三七素、黄酮有效成分,具有止血、活血化瘀、消肿定痛、滋补强壮、抗疲劳、耐缺氧、抗衰老、降血脂、降血压、提高机体免疫功能等作用,可扩张血管,溶解血栓,改善微循环,预防和治疗高血脂、胆固醇增高、冠心病、心绞痛、脑溢血后遗症等心脑血管疾病;脂肪肝、肝纤维化等肝病以及失血、产后、久病等原因导致的体虚症。
牛骨胶原蛋白肽:肽骨吸收,对中老年骨骼、骨关节、缺钙、骨质疏松有很好效果;
叶酸:叶酸对细胞的分裂生长及核酸、氨基酸、蛋白质的合成起着重要的作用,在本发明中与烟酸共同作用起到消栓通络作用;
烟酸:烟酸有较强的扩张周围血管作用,促进血液循环,使血压下降;
维生素C:抗坏血,抗氧化作用;提高细胞的抵抗力,保持血管的弹性,消除体内的尼古丁;
香菇多糖:香菇多糖是从优质香菇子实体中提取的有效活性成分,香菇多糖具有抗病毒、抗肿瘤、调节免疫功能和刺激干扰素形成等作用,能够提高人体免疫力。
本发明的保健饮品的服用方法:根据人体体重,90-120斤的人群,一日三次,每次30ml,饭前服用;120斤以上,一日三次,每次60ml,饭前服用;胃炎、胃溃疡患者或者严重心脏病患者于饭后1小时后服用。
禁忌:服用本发明的保健饮品期间,禁烟、酒及碱性食物,服用两小时内不宜平躺。
具体实施方式
下面结合具体的实施例对本发明作进一步的描述。
实施例1:一种中老年保健饮品,以100Kg的本发明的成品为例进行说明,由以下重量的原料组成,三七粉0.5Kg、牛骨胶原蛋白肽1.5Kg、叶酸0.3Kg、烟酸0.6 Kg、维生素C0.6Kg、香菇多糖0.5Kg、水96Kg。
一种制备上述的中老年保健饮品的方法,包括以下步骤:按照以下重量份数称取原料:三七粉0.5Kg、牛骨胶原蛋白肽1.5Kg、叶酸0.3Kg、烟酸0.6 Kg、维生素C 0.6Kg、香菇多糖0.5Kg;将以上原料放入容皿中,按照原料:水为1:25的比例向容皿中加入水,中火熬制12分钟后,过滤,取滤液,加入纯净水进行稀释,稀释浓度达到4%,装瓶即可。
实施例2:一种中老年保健饮品,以100Kg的本发明的成品为例进行说明,由以下重量的原料组成,三七粉1Kg、牛骨胶原蛋白肽1.7Kg、叶酸0.6 Kg、烟酸1.2 Kg、维生素C 1.5Kg、香菇多糖1 Kg、水93Kg。
实施例3:一种中老年保健饮品,以100Kg的本发明的成品为例进行说明,由以下重量的原料组成,三七粉0.8Kg、牛骨胶原蛋白肽1.6Kg、叶酸0.4 Kg、烟酸0.7 Kg、维生素C1.2 Kg、香菇多糖0.8 Kg、水94.5 Kg。
一种制备上述的中老年保健饮品的方法,包括以下步骤:按照以下重量份数称取原料:三七粉0.8Kg、牛骨胶原蛋白肽1.6Kg、叶酸0.4 Kg、烟酸0.7 Kg、维生素C 1.2 Kg、香菇多糖0.8 Kg;将以上原料放入容皿中,按照原料:水为1:10的比例向容皿中加入水,中火熬制20分钟后,过滤,取滤液,加入纯净水进行稀释,稀释浓度达到5.5%,装瓶即可。
实施例4:一种中老年保健饮品,以100Kg的本发明的成品为例进行说明,由以下重量的原料组成,三七粉0.7Kg、牛骨胶原蛋白肽1.6Kg、叶酸0.4Kg、烟酸0.8 Kg、维生素C 0.9Kg、香菇多糖0.6Kg、水95Kg。
一种制备上述的中老年保健饮品的方法,包括以下步骤:按照以下重量份数称取原料:三七粉0.7Kg、牛骨胶原蛋白肽1.6Kg、叶酸0.4Kg、烟酸0.8Kg、维生素C 0.9 Kg、香菇多糖0.6Kg;将以上原料放入容皿中,按照原料:水为1:19的比例向容皿中加入水,中火熬制16分钟后,过滤,取滤液,加入纯净水进行稀释,稀释浓度达到5%,装瓶即可。
实施例5:一种中老年保健饮品,以100Kg的本发明的成品为例进行说明,由以下重量的原料组成,三七粉0.9 Kg、牛骨胶原蛋白肽1.9 Kg、叶酸0.5 Kg、烟酸1 Kg、维生素C1.2 Kg、香菇多糖0.9 Kg、水93.6Kg。
一种制备上述的中老年保健饮品的方法,包括以下步骤:按照以下重量份数称取原料:三七粉0.9 Kg、牛骨胶原蛋白肽1.9 Kg、叶酸0.5 Kg、烟酸1 Kg、维生素C 1.2 Kg、香菇多糖0.9 Kg;将以上原料放入容皿中,按照原料:水为1:20的比例向容皿中加入水,中火熬制15分钟后,过滤,取滤液,加入纯净水进行稀释,稀释浓度达到6.4%,装瓶即可。
实施例6:一种中老年保健饮品,以100Kg的本发明的成品为例进行说明,由以下重量的原料组成,三七粉0.75 Kg、牛骨胶原蛋白肽1.7 Kg、叶酸0.45 Kg、烟酸0.95Kg、维生素C 1.1 Kg、香菇多糖0.7Kg、水94.35Kg。
实施例7:一种中老年保健饮品,以100Kg的本发明的成品为例进行说明,由以下重量的原料组成,三七粉0.8 Kg、牛骨胶原蛋白肽1.7 Kg、叶酸0.45 Kg、烟酸0.9 Kg、维生素C1 Kg、香菇多糖0.85 Kg、水94.3 Kg。
一种制备上述的中老年保健饮品的方法,包括以下步骤:按照以下重量份数称取原料:三七粉0.8 Kg、牛骨胶原蛋白肽1.7 Kg、叶酸0.45 Kg、烟酸0.9 Kg、维生素C 1 Kg、香菇多糖0.85 Kg;将以上原料放入容皿中,按照原料:水为1:18的比例向容皿中加入水,中火熬制16分钟后,过滤,取滤液,加入纯净水进行稀释,稀释浓度达到5.7%,装瓶即可。
下面列举服用过本发明的中老年保健饮品的临床病例,来说明本发明的有益效果:
病例1:刘某,男,55岁,患高血压、脑血栓、偏瘫七年,不能正常说话、走路不稳、高血压、头晕头疼,手麻、服用2周后,手麻现象有所好转,服用一个月后,可以慢走,尝试短句的说话,胳膊可以自由抬举。
病例2:钱某,男,74岁,患前期胃癌及尿毒症,久治不愈,浑身淤肿,行走不便,服用本发明的保健饮品2周后,淤肿消失,服用两个月后,能够自身独立行走不用人搀扶。
病例3:杨某,男,47岁,患股骨头坏死一年,服用本发明的保健饮品6天后,患处开始发热、发燥、发痒,继续服用2个月后,能够在人的搀扶下缓慢走路。
病例4:钱某,女,28岁,患子宫囊肿八年,两个囊块大到八厘米,服用本发明的保健饮品3周后,囊块明显开始缩小,继续服用1个月后,出血现象完全没有了,生理期恢复正常。
Claims (4)
1.一种中老年保健饮品,其特征在于:由以下质量份数的原料组成,三七粉0.5-1份、牛骨胶原蛋白肽1.5-2份、叶酸0.3-0.6份、烟酸0.6-1.2份、维生素C 0.6-1.5份、香菇多糖0.5-1份、水93-96份。
2.根据权利要求1所述的中老年保健饮品,其特征在于:由以下质量份数的原料组成,三七粉0.7-0.9份、牛骨胶原蛋白肽1.6-1.9份、叶酸0.4-0.5份、烟酸0.8-1份、维生素C0.9-1.2份、香菇多糖0.6-0.9份、水94-95份。
3.根据权利要求1所述的中老年保健饮品,其特征在于:由以下质量份数的原料组成,三七粉0.8份、牛骨胶原蛋白肽1.7份、叶酸0.45份、烟酸0.9份、维生素C 1份、香菇多糖0.85份、水94.3份。
4.一种制备如权利要求1所述的中老年保健饮品的方法,其特征在于:包括以下步骤:按照以下重量份数称取原料:三七粉0.5-1份、牛骨胶原蛋白肽1.5-2份、叶酸0.3-0.6份、烟酸0.6-1.2份、维生素C 0.6-1.5份、香菇多糖0.5-1份;将以上原料放入容皿中,按照原料:水为1:25-1:10的比例向容皿中加入水,中火熬制12-20分钟后,过滤,取滤液,加入纯净水进行稀释,稀释浓度达到4%-7.3%,装瓶即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711288925.0A CN107981141A (zh) | 2017-12-07 | 2017-12-07 | 一种中老年保健饮品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711288925.0A CN107981141A (zh) | 2017-12-07 | 2017-12-07 | 一种中老年保健饮品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107981141A true CN107981141A (zh) | 2018-05-04 |
Family
ID=62036516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711288925.0A Pending CN107981141A (zh) | 2017-12-07 | 2017-12-07 | 一种中老年保健饮品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107981141A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1994133A (zh) * | 2006-12-21 | 2007-07-11 | 杨林伟 | 胶原蛋白肽在食品中的应用方法 |
CN103385347A (zh) * | 2013-08-08 | 2013-11-13 | 吴长海 | 一种胶原复合肽粉 |
CN103750450A (zh) * | 2013-12-27 | 2014-04-30 | 秦燕 | 一种香菇多糖饮品及其制备方法 |
CN106617102A (zh) * | 2017-01-17 | 2017-05-10 | 吉速利(上海)健康科技股份有限公司 | 胶原蛋白营养粉及其制备方法 |
-
2017
- 2017-12-07 CN CN201711288925.0A patent/CN107981141A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1994133A (zh) * | 2006-12-21 | 2007-07-11 | 杨林伟 | 胶原蛋白肽在食品中的应用方法 |
CN103385347A (zh) * | 2013-08-08 | 2013-11-13 | 吴长海 | 一种胶原复合肽粉 |
CN103750450A (zh) * | 2013-12-27 | 2014-04-30 | 秦燕 | 一种香菇多糖饮品及其制备方法 |
CN106617102A (zh) * | 2017-01-17 | 2017-05-10 | 吉速利(上海)健康科技股份有限公司 | 胶原蛋白营养粉及其制备方法 |
Non-Patent Citations (2)
Title |
---|
白鸿: "《保健食品功效成分检测方法》", 31 May 2011 * |
陈信云等: "《中药学 第3版》", 31 January 2017 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048210B (zh) | 一种具有缓解疲劳功能的红枣保健饮料 | |
CN103860903B (zh) | 一种降血压、降血糖、降血脂的药酒 | |
CN106418545A (zh) | 一种营养均衡的功能性食品 | |
CN106511641A (zh) | 一种具有治疗痛风功效的青梅纳豆组合物及其制备方法 | |
CN107252095A (zh) | 复合酵素及其制备方法 | |
CN100574786C (zh) | 一种甲鱼制剂的生产工艺 | |
CN101422242B (zh) | 一种补气养血、益气健脾的保健食品及其制备方法 | |
CN103263054B (zh) | 一种降血压功能性饮品 | |
CN1311857C (zh) | 一种健身益寿食疗口服液 | |
CN100348238C (zh) | 一种保健口服液 | |
CN1060028C (zh) | 一种主要由谷物瓜菜果组成的健康食品 | |
CN107981141A (zh) | 一种中老年保健饮品及其制备方法 | |
CN108114222A (zh) | 一种补气健脾滋补肝肾的中药组合物及其制备方法 | |
CN106038743A (zh) | 一种降血压冲剂、制备方法及其应用 | |
CN103316217B (zh) | 一种治疗心脏病的中药制剂及其制备方法 | |
CN102813760B (zh) | 一种具有降血脂功能的天然药食同源原料组成及制备方法 | |
CN110841008A (zh) | 一种乌骨羊胎盘月子酒及其制备方法 | |
CN102334715A (zh) | 天然水蛭素酸性多肽饮液及其制备方法 | |
CN107158249A (zh) | 健脑通络酒及其制备方法 | |
CN108452047B (zh) | 延缓衰老抑制肿瘤细胞生长改善心脑血管微循环的组合物 | |
CN106620282A (zh) | 一种金钗石斛西洋参胶囊及其制备方法 | |
KR20010088749A (ko) | 한약재가 포함된 사상체질별 한방 라면 | |
CN105214068A (zh) | 一种治疗小儿多发性抽动症的营养组合物及其制备方法 | |
CN103610953A (zh) | 一种滋阴健阳的海参胶囊的制造方法 | |
CN104351668A (zh) | 白芸豆银耳营养粥及制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180504 |
|
RJ01 | Rejection of invention patent application after publication |